The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
The fibrin-derived γ377-395 peptide inhibits microglia activation and suppresses relapsing paralysis in central nervous system autoimmune disease
Open accessAbstract
Perivascular microglia activation is a hallmark of inflammatory demyelination in multiple sclerosis (MS), but the mechanisms underlying microglia activation and specific strategies to attenuate their activation remain elusive. Here, we identify fibrinogen as a novel regulator of microglia activation and show that targeting of the interaction of fibrinogen with the microglia integrin receptor Mac-1 (alpha(M)beta(2), CD11b/CD18) is sufficient to suppress experimental autoimmune encephalomyelitis in mice that retain full coagulation function. We show that fibrinogen, which is deposited perivascularly in MS plaques, signals through Mac-1 and induces the differentiation of microglia to phagocytes via activation of Akt and Rho. Genetic disruption of fibrinogen-Mac-1 interaction in fibrinogen-gamma(390-396A) knock-in mice or pharmacologically impeding fibrinogen-Mac-1 interaction through intranasal delivery of a fibrinogen-derived inhibitory peptide (gamma(377-395)) attenuates microglia activation and suppresses relapsing paralysis. Because blocking fibrinogen-Mac-1 interactions affects the proinflammatory but not the procoagulant properties of fibrinogen, targeting the gamma(377-395) fibrinogen epitope could represent a potential therapeutic strategy for MS and other neuroinflammatory diseases associated with blood-brain barrier disruption and microglia activation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



![Figure 4. Fibγ390-396A mice have reduced clinical scores and microglia activation in EAE. (A) Clinical scores of MOG35-55–immunized mice. Fibγ390-396A mice (blue triangles; n = 29) show statistically significant lower clinical scores (*, P < 0.01) than FibγWT control mice (black squares; n = 28). (B) Individual clinical scores from Fibγ390-396A and FibγWT mice on days 20 (average clinical score, 3.3 ± 0.22 for FibγWT [n = 19] vs. 2.1 ± 0.32 for Fibγ390-396A [n = 20]; P < 0.01) and 31 after immunization (average clinical score, 2.8 ± 0.25 for FibγWT [n = 15] vs. 1.5 ± 0.23 for Fibγ390-396A [n = 20]; P < 0.001). (C) Histological analysis of spinal cord sections stained with hematoxylin/eosin revealed increased inflammation in the FibγWT mice versus the Fibγ390-396A mice. (D) Survival curve of Fibγ390-396A and FibγWT mice after MOG35-55 immunization. Fibγ390-396A had a greater survival rate than the FibγWT mice. (E) Rotarod analysis of Fibγ390-396A and FibγWT mice on day 13. Fibγ390-396A significantly outperformed their wild-type counterparts in a behavioral test designed to assess motor skill function. n = 7 mice per group. **, P < 0.05. (F) Increased activation of IsoB4+ cells in FibγWT mice as compared with Fibγ390-396A mice. Bar, 58 μm. Data are represented as the mean clinical score and are mean ± SEM.](https://figures.cochat.ai/paper-figures/a0547757dbd947b08e158d353bae9525/the-fibrin-derived-377-395-peptide-inhibits-microglia-activation-and-suppresses-figure-4.jpg)




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Fggγ390–396A knock-in mice, which express fully coagulable fibrinogen that selectively lacks the CD11b receptor binding site (Adams et al., 2007; Flick et al., 2004).”
From Fibrinogen induces microglia-mediated spine elimination and cognitive impairment in an Alzheimer's disease model (2019) · cites this paper as Adams et al., 2007
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo
Nimmerjahn, A., Kirchhoff, F., & Helmchen, F. (2005) · Science · doi:10.1126/science.1110647 · Cited by 5,827
New Perspectives in Cell Adhesion: RGD and Integrins
Ruoslahti, E., & Pierschbacher, M. D. (1987) · Science · doi:10.1126/science.2821619 · Cited by 4,865
RGD AND OTHER RECOGNITION SEQUENCES FOR INTEGRINS
Ruoslahti, E. (1996) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.12.1.697 · Cited by 3,191 · cited 1×
“For peptide- recognizing integrin receptors, such as the RGD-recognizing αvβ3 and α5β1 integrins, both the peptide itself and antibodies against the peptide may inhibit integrin-mediated biological eff ects (49-52).”
BackgroundInflammatory Blockade Restores Adult Hippocampal Neurogenesis
Monje, M. L., Toda, H., & Palmer, T. D. (2003) · Science · doi:10.1126/science.1088417 · Cited by 2,426
Isaacson, P. G., Dogan, A., Price, S. K., & Spencer, J. (1989) · The American Journal of Surgical Pathology · doi:10.1097/00000478-198912000-00004 · Cited by 1,915
Lock, C., Hermans, G., Pedotti, R., Brendolan, A., Schadt, E., Garren, H., Langer-Gould, A., Strober, S., Cannella, B., Allard, J., et al. (2002) · Nature Medicine · doi:10.1038/nm0502-500 · Cited by 1,669
Youssef, S., Stüve, O., Patarroyo, J. C., Ruiz, P. J., Radosevich, J. L., Hur, E. M., Bravo, M., Mitchell, D. J., Sobel, R. A., Steinman, L., et al. (2002) · Nature · doi:10.1038/nature01158 · Cited by 1,097
Lehnardt, S., Massillon, L., Follett, P., Jensen, F. E., Ratan, R., Rosenberg, P. A., Volpe, J. J., & Vartanian, T. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1432609100 · Cited by 1,052
Identification of two distinct mechanisms of phagocytosis controlled by different Rho GTPases
Caron, E., & Hall, A. (1998) · Science · doi:10.1126/science.282.5394.1717 · Cited by 1,019
Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis
Greter, M., Heppner, F. L., Lemos, M. P., Odermatt, B. M., Goebels, N., Laufer, T., Noelle, R. J., & Becher, B. (2005) · Nature Medicine · doi:10.1038/nm1197 · Cited by 862 · cited 1×
“The CD11c+ perivascular dendritic cells are responsible for the presentation of myelin antigens (58, 59).”
Background
Research works printed but not linked: 6
- 2001, Trends Mol. Med., 7, 115
- 2004, Mol. Interv., 4, 163
- 1976, Fed. Proc., 35, 2428
- 1978, J. Lab. Clin. Med., 91, 592
- 2002, Biol. Chem., 383, 37
- 1991, Am. J. Pathol., 139, 1401
Cited by
Microglial physiology: unique stimuli, specialized responses
Ransohoff, R. M., & Perry, V. H. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132528 · Cited by 1,858
A polarizing question: do M1 and M2 microglia exist?
Ransohoff, R. M. (2016) · Nature Neuroscience · doi:10.1038/nn.4338 · Cited by 1,573
Microglial Activation and Chronic Neurodegeneration
Lull, M. E., & Block, M. L. (2010) · Neurotherapeutics · doi:10.1016/j.nurt.2010.05.014 · Cited by 1,047
Fibrinogen as a key regulator of inflammation in disease
Davalos, D., & Akassoglou, K. (2012) · Seminars in Immunopathology · doi:10.1007/s00281-011-0290-8 · Cited by 922
Self-citationWhy neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression
Gao, H.-M., & Hong, J.-S. (2008) · Trends in Immunology · doi:10.1016/j.it.2008.05.002 · Cited by 821
Metadata
- Authors
- Adams, R. A., Bauer, J., Flick, M. J., Sikorski, S. L., Nuriel, T., Lassmann, H., Degen, J. L., & Akassoglou, K.
- Affiliations
- University of California San Diego (US)
- Medical University of Vienna (AT)
- University of Cincinnati (US)
- ORCID
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2007-03-05
- Volume
- 204
- Issue
- 3
- Pages
- 571-582
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2137908
- OpenAlex
- W2142424019
- Cited by
- 335
- References
- 72
- Citations by year
- 2026: 11 · 2025: 16 · 2024: 19 · 2023: 22 · 2022: 16 · 2021: 27 · 2020: 21 · 2019: 16 · 2018: 21 · 2017: 16 · 2016: 19 · 2015: 18 · 2014: 15 · 2013: 17 · 2012: 18
- FWCI
- 11.33
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- cc-by-nc-sa
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by-nc-sa)
- Funders
- National Institute of Neurological Disorders and Stroke (R01NS052189, P30NS047101, R01NS051470)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Hematology › Blood properties and coagulation
- Keywords
- fibrinogen, microglial activation, Mac-1, CD11b/CD18, multiple sclerosis, experimental autoimmune encephalomyelitis, inflammatory demyelination, Akt signaling, Rho GTPase signaling, blood-brain barrier disruption, neuroinflammation
- MeSH terms
- Amino Acid Sequence, Animals, Cells, Cultured, Female, Fibrin, Fibrinogen, Mice, Inbred C57BL, Molecular Sequence Data, Peptide Fragments, Macrophage-1 Antigen, Microglia, Multiple Sclerosis, Relapsing-Remitting, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The fibrin-derived γ377-395 peptide inhibits microglia activation and suppresses relapsing paralysis in central nervous system autoimmune disease. https://app.cochat.ai/papers/10.1084/jem.20061931
- The paper
- Adams, R. A., Bauer, J., Flick, M. J., Sikorski, S. L., Nuriel, T., Lassmann, H., Degen, J. L., & Akassoglou, K. (2007). The fibrin-derived γ377-395 peptide inhibits microglia activation and suppresses relapsing paralysis in central nervous system autoimmune disease. The Journal of Experimental Medicine. https://doi.org/10.1084/jem.20061931
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.